Evaluation of Patient's Knowledge of Their NACO Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03323320

Enrollment

Registered

2017-10-27

Start date

2016-12-05

Completion date

2017-11-01

Last updated

2018-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anticoagulant

Brief summary

More than one million of patient receive anti vitamine K treatment which is the main cause of hospitalization. About 50 000 patient receive direct oral anticoagulant . The aim is to evaluate the patient's level of knowledge about their anticoagulant treatment and specially about the side effect

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient with AOD treatment * capable to answer to questionnaire * with or without antivitamin K

Exclusion criteria

* dementia * cognitive trouble * refusing participation

Design outcomes

Primary

Measure	Time frame	Description
questionnaire score >80%	Day 1	it's a questionnaire about anticoagulant treatment ; each question has a score ans for the study investigators calculate the total

Countries

France

Outcome results